---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-23-059044"
form_type: "8-K"
ticker: "ABVC"
cik: "0001173313"
company_name: "ABVC BIOPHARMA, INC."
filed_at: "2023-07-24T23:59:59+00:00"
generated_at: "2026-06-13T04:02:46.420811+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# ABVC BioPharma executes 1-for-10 reverse stock split effective July 25, 2023 to regain Nasdaq compliance

## Summary
- 1-for-10 reverse stock split effective 12:01 a.m. EST July 25, 2023; new CUSIP 00091F 304.
- Pre-split outstanding shares 33,080,740; post-split approx 3,308,074 (no fractional shares, rounded up).
- Shareholder approval obtained at special meeting on July 7, 2023.
- Ticker symbol remains ABVC; split aims to increase per-share price to meet Nasdaq continued listing standards.
- Board expects reverse split to help exit penny-stock status and attract broader investor base.

## SEC filing metadata
- accession: 0001213900-23-059044
- form_type: 8-K
- ticker: ABVC
- cik: 0001173313
- company_name: ABVC BIOPHARMA, INC.
- filed_at: 2023-07-24T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 2.02, 3.03, 5.03, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1173313/000121390023059044/0001213900-23-059044-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1173313/000121390023059044/ea182176-8k_abvcbio.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-23-059044
- JSON: https://secwatch.observer/filing/0001213900-23-059044.json
- Plain text: https://secwatch.observer/filing/0001213900-23-059044.txt

## Key facts
- Governance Changes
  ABVC BIOPHARMA, INC.: Filed a Certificate of Amendment to Articles of Incorporation to effect a 1-for-10 reverse stock split (effective 2023-07-25).
  - Change: charter amendment
  - Effective: 2023-07-25
  source text: ABVC BioPharma, Inc. (the “Company”) filed a Certificate of Amendment to its Articles of Incorporation (the “Certificate”) to be effective as of 12:01 a.m. EST on July 25, 2023 authorizing a 1-for-10 reverse stock split of the issued and outstanding shares of its common stock
  evidence_url: https://www.sec.gov/Archives/edgar/data/1173313/000121390023059044/0001213900-23-059044-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.